Facebook
Twitter
LinkedIn
ForwardSubstance Use Disorders and the Brain in the Geriatric Population
| Registration |
|---|
You must log in or create an account before enrolling in this educational activity. Once you register for the course, you will have 30 days from the date of enrollment to complete the course. The date your access expires will be indicated in the Course Summary box on this webpage. |
Purpose
The current global pandemic has impacted persons with substance use disorders, including the geriatric population. Substance use disorders can negatively impact older adults, and the neurobiology of addictions will be reviewed.
Target Audience
Healthcare professionals.
Objectives
- Define Substance Use Disorders.
- Describe ways to screen for substance use disorders in the geriatric population.
- List common substances of misuse and how they impact the brain.
- Discuss the treatment of substance use disorders in the geriatric population.
Terms of Use and Privacy Policy
Recording date: November 12, 2021
Date of original release: January 7, 2022
Most recent review/update: January 7, 2022
Termination date: January 6, 2025
Michelle Davids, DO
Outpatient Mental Health, Broadlawns Medical Center
- Medical School: Chicago College of Osteopathic Medicine, Downers Grove, IL
- Residency: Harvard South Shore Psychiatry Residency, Boston, Massachusetts
- Fellowship: Harvard Medical School, Partners Addiction Psychiatry Fellowship, Boston, Massachusetts
- Board Certifications: American Board of Psychiatry and Neurology (General Psychiatry); American Board of Psychiatry and Neurology (Addiction Psychiatry)
- Clinical Interests/Additional Certifications: Diplomat of the American Board of Lifestyle Medicine / Addiction Psychiatry, Lifestyle Medicine
Dhrumil Patel, MD
Fourth Year Resident, Broadlawns UnityPoint Psychiatry Residency Program
Medical School: Smt. NHL Municipal Medical College, Gujarat University - Ahmedabad, India
Accreditation Statements
MD: This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Iowa Medical Society (IMS). Des Moines University (DMU) is accredited by the IMS to provide continuing medical education for physicians. DMU designates this enduring materials activity for a maximum of 0.75 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.- DO: Des Moines University (DMU) is accredited by the American Osteopathic Association (AOA) to provide osteopathic continuing medical education for physicians. DMU designates this activity for a maximum of 0.75 AOA Category 1-B credits and will report CME and specialty credits commensurate with the extent of the physician’s participation in this activity.
- Other Healthcare Professionals: This enduring materials activity is designated for a maximum of 0.75 AMA PRA Category 1 Credit(s)™.
Educational Grants
No ineligible company provided financial support for this continuing education activity.
DISCLOSURE
The planning committee member(s) and speaker(s) will disclose if any pharmaceuticals or medical procedures and devices discussed are investigational or unapproved for use by the U.S. Food and Drug Administration (FDA). Determination of educational content and the selection of speakers is the responsibility of the activity director.
Relevant to the content of this educational activity, the following individual(s) have no conflict(s) with ineligible companies to disclose.
- Kathleen Laurin, PhD, Speaker
Disclaimer
The information provided at this activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient’s medical condition. The content of each presentation does not necessarily reflect the views of Des Moines University.
Available Credit
- 0.75 AMA PRA Category 1 Credits™
- 0.75 AOA Category 1B
- 0.75 CE Contact Hour(s)